EicOsis
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1930 5th St Ste A, Davis, California, 95...Phone Number
(530) 338-0070Website
www.eicosis.comRevenue
<$5 MillionIndustry
About EicOsis
EicOsis is focused on developing innovative treatments for chronic pain and inflammation by targeting the soluble Epoxide Hydrolase enzyme, aiming to restore the body's natural healing abilities. The company is committed to addressing the urgent need for safe, non-addictive pain medications, particularly in light of the opioid crisis affecting millions in the U.S. Their lead drug candidate is currently undergoing Phase 1 clinical trials, with a focus on providing effective solutions for patients suffering from neuropathic pain and other inflammatory conditions. EicOsis seeks to improve the quality of life for individuals impacted by chronic pain through their novel therapeutic approaches.Explore more
EicOsis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to EicOsis
Compare insights from companies similar to EicOsis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
EicOsis Tech Stack
A closer look at the technologies used by EicOsis
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding EicOsis
Sign Up For FreeTo access detailed company insights
EicOsis is focused on developing innovative treatments for chronic pain and inflammation by targeting the soluble Epoxide Hydrolase enzyme, aiming to restore the body's natural healing abilities. The company is committed to addressing the urgent need for safe, non-addictive pain medications, particularly in light of the opioid crisis affecting mill... Read More
